Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study.
Journal: Brain, behavior, and immunity
Published: December 20, 2023
Corrigendum to "Genetic predisposition to major depressive disorder differentially impacts alcohol consumption and high-risk drinking situations in men and women with alcohol use disorder" [Drug Alcohol Depend. 243 (2023) 109753].
Journal: Drug and alcohol dependence
Published: July 12, 2023
Epigenetic regulation of GABA catabolism in iPSC-derived neurons: The molecular links between FGF21 and histone methylation.
Journal: Molecular metabolism
Published: April 26, 2023
Genetic predisposition to major depressive disorder differentially impacts alcohol consumption and high-risk drinking situations in men and women with alcohol use disorder.
Journal: Drug and alcohol dependence
Published: August 19, 2022
Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder.
Journal: Frontiers in pharmacology
Published: July 05, 2022
Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolism.
Journal: Molecular metabolism
Published: May 09, 2022
Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder.
Journal: Molecular psychiatry
Published: May 02, 2022
Showing 1-7 of 7
Last Updated: 09/26/2026